{
    "clinical_study": {
        "@rank": "144555", 
        "arm_group": {
            "arm_group_label": "peripheral blood mononuclear cells", 
            "arm_group_type": "Experimental", 
            "description": "peripheral blood mononuclear cells will be injected to calf muscle of critical limb ischemia"
        }, 
        "brief_summary": {
            "textblock": "The purpose of this study is to determine the safety and efficacy of G-CSF-mobilized\n      autologous peripheral blood mononuclear cell injection to ischemic limbs of patients with\n      critical limb ischemia."
        }, 
        "brief_title": "Treatment of Chronic Critical Limb Ischemia With G-CSF-mobilized Autologous Peripheral Blood Mononuclear Cells", 
        "completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Critical Limb Ischemia", 
            "Atherosclerosis", 
            "Ischemic Ulcer", 
            "Gangrene"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Atherosclerosis", 
                "Gangrene", 
                "Ischemia", 
                "Ulcer"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patients with critical limb ischemia confirmed by toe pressure, ABI, TCOM\n\n          -  Levels of arterial occlusion are femoropopliteal or tibioperoneal occlusion\n\n          -  Poor distal artery runoff\n\n          -  Age 18-70 year\n\n        Exclusion Criteria:\n\n          -  Planned for major amputation within 4 weeks\n\n          -  Receive blood component within 4 weeks\n\n          -  Acute myocardial infarction\n\n          -  severe valvular heart disease\n\n          -  renal failure\n\n          -  liver failure\n\n          -  Cancer\n\n          -  Hypercoagulable state\n\n          -  Severe infection\n\n          -  Pregnancy"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "70 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "10", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "April 9, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01833585", 
            "org_study_id": "SIRIRAJR015533013"
        }, 
        "intervention": {
            "arm_group_label": "peripheral blood mononuclear cells", 
            "description": "Peripheral blood mononuclear cell solution 59 cc will be injected to the gastrocnemius muscle of ischemic limb of patients with critical limb ischemia", 
            "intervention_name": "Peripheral blood mononuclear cell", 
            "intervention_type": "Biological"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "critical limb ischemia", 
            "atherosclerosis", 
            "ischemic ulcer", 
            "rest pain", 
            "gangrene"
        ], 
        "lastchanged_date": "April 14, 2013", 
        "location": {
            "contact": {
                "email": "nutttawut@gmail.com", 
                "last_name": "Nuttawut Sermsathanasawadi, MD., Ph.D"
            }, 
            "facility": {
                "address": {
                    "city": "Bangkoknoi", 
                    "country": "Thailand", 
                    "state": "Bangkok", 
                    "zip": "10700"
                }, 
                "name": "Vascular Surgery, Siriraj Hospital, Mahidol University"
            }, 
            "investigator": {
                "last_name": "Nuttawut Sermsathanasawadi, MD., Ph.D", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Thailand"
        }, 
        "number_of_arms": "1", 
        "official_title": "Pilot Study of Treatment of Chronic Critical Limb Ischemia With G-CSF-mobilized Autologous Peripheral Blood Mononuclear Cells", 
        "overall_contact": {
            "email": "nuttawut@gmail.com", 
            "last_name": "Nuttawut Sermsathanasawadi, MD.,Ph.D"
        }, 
        "overall_official": {
            "affiliation": "Mahidol University", 
            "last_name": "Nuttawut Sermsathanasawadi, MD.,Ph.D.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Thailand: Ethical Committee", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Number of patients without major amputation after mononuclear cell injection", 
            "safety_issue": "Yes", 
            "time_frame": "3 month"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01833585"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Mahidol University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Mahidol University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "April 2013", 
        "study_design": "Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "April 2013"
    }
}